Registro:

Referencias:

• De Kloet, E.R., Joels, M., Holsboer, F., Stress and the brain: From adaptation to disease (2005) Nature Reviews: Neuroscience, 6, pp. 463-475
• Bale, T.L., Vale, W.W., CRF and CRF receptors: Role in stress responsivity and other behaviors (2004) Annual Review of Pharmacology and Toxicology, 44, pp. 525-557
• Smith, G.W., Aubry, J.M., Dellu, F., Contarino, A., Bilezikjian, L.M., Gold, L.H., Chen, R., Bentley, C.A., Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development (1998) Neuron, 20, pp. 1093-1102
• Korosi, A., Baram, T.Z., The central corticotropin releasing factor system during development and adulthood (2008) European Journal of Pharmacology, 583, pp. 204-214
• Maras, P.M., Baram, T.Z., Sculpting the hippocampus from within: Stress, spines, and CRH (2012) Trends in Neurosciences, 35, pp. 315-324
• Paez-Pereda, M., Hausch, F., Holsboer, F., Corticotropin releasing factor receptor antagonists for major depressive disorder (2011) Expert Opinion on Investigational Drugs, 20, pp. 519-535
• Sanders, J., Nemeroff, C., The CRF system as a therapeutic target for neuropsychiatric disorders (2016) Trends in Pharmacological Sciences, 37, pp. 1045-1054
• Vale, W., Spiess, J., Rivier, C., Rivier, J., Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin (1981) Science, 213, pp. 1394-1397
• Hauger, R.L., Risbrough, V., Brauns, O., Dautzenberg, F.M., Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: New molecular targets (2006) CNS and Neurological Disorders Drug Targets, 5, pp. 453-479
• Hillhouse, E.W., Grammatopoulos, D.K., The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: Implications for physiology and pathophysiology (2006) Endocrine Reviews, 27, pp. 260-286
• Arzt, E., Holsboer, F., CRF signaling: Molecular specificity for drug targeting in the CNS (2006) Trends in Pharmacological Sciences, 27, pp. 531-538
• Sapolsky, R.M., Romero, L.M., Munck, A.U., How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions (2000) Endocrine Reviews, 21, pp. 55-89
• Herman, J.P., Figueiredo, H., Mueller, N.K., Ulrich-Lai, Y., Ostrander, M.M., Choi, D.C., Cullinan, W.E., Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness (2003) Frontiers in Neuroendocrinology, 24, pp. 151-180
• Quax, R.A., Manenschijn, L., Koper, J.W., Hazes, J.M., Lamberts, S.W., Van Rossum, E.F., Feelders, R.A., Glucocorticoid sensitivity in health and disease (2013) Nature Reviews: Endocrinology, 9, pp. 670-686
• Britton, D.R., Koob, G.F., Rivier, J., Vale, W., Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty (1982) Life Sciences, 31, pp. 363-367
• Sutton, R.E., Koob, G.F., Le Moal, M., Rivier, J., Vale, W., Corticotropin releasing factor produces behavioural activation in rats (1982) Nature, 297, pp. 331-333
• Koob, G.F., Bloom, F.E., Corticotropin-releasing factor and behavior (1985) Federation Proceedings, 44, pp. 259-263
• Dunn, A.J., File, S.E., Corticotropin-releasing factor has an anxiogenic action in the social interaction test (1987) Hormones and Behavior, 21, pp. 193-202
• Eaves, M., Thatcher-Britton, K., Rivier, J., Vale, W., Koob, G.F., Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats (1985) Peptides, 6, pp. 923-926
• Henckens, M.J., Deussing, J.M., Chen, A., Region-specific roles of the corticotropin-releasing factor-urocortin system in stress (2016) Nature Reviews: Neuroscience, 17, pp. 636-651
• Gallagher, J.P., Orozco-Cabal, L.F., Liu, J., Shinnick-Gallagher, P., Synaptic physiology of central CRH system (2008) European Journal of Pharmacology, 583, pp. 215-225
• Valentino, R.J., Van Bockstaele, E., Convergent regulation of locus coeruleus activity as an adaptive response to stress (2008) European Journal of Pharmacology, 583, pp. 194-203
• Perez-Castro, C., Renner, U., Haedo, M.R., Stalla, G.K., Arzt, E., Cellular and molecular specificity of pituitary gland physiology (2012) Physiological Reviews, 92, pp. 1-38
• Reul, J.M., Holsboer, F., Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression (2002) Current Opinion in Pharmacology, 2, pp. 23-33
• Kovacs, K.J., CRH: The link between hormonal-, metabolic- and behavioral responses to stress (2013) Journal of Chemical Neuroanatomy, 54, pp. 25-33
• Kratzer, S., Mattusch, C., Metzger, M.W., Dedic, N., Noll-Hussong, M., Kafitz, K.W., Eder, M., Kochs, E., Activation of CRH receptor type 1 expressed on glutamatergic neurons increases excitability of CA1 pyramidal neurons by the modulation of voltage-gated ion channels (2013) Frontiers in Cellular Neuroscience, 7, p. 91
• Jedema, H.P., Grace, A.A., Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro (2004) Journal of Neuroscience, 24, pp. 9703-9713
• Tao, J., Zhang, Y., Soong, T.W., Li, S., Expression of urocortin 2 and its inhibitory effects on intracellular ca2+ via L-type voltage-gated calcium channels in rat pheochromocytoma (PC12) cells (2006) Neuropsychopharmacology, 31, pp. 2600-2609
• Kim, Y., Park, M.K., Uhm, D.Y., Chung, S., Modulation of T-type Ca2+ channels by corticotropin-releasing factor through protein kinase C pathway in MN9D dopaminergic cells (2007) Biochemical and Biophysical Research Communications, 358, pp. 796-801
• Tao, J., Hildebrand, M.E., Liao, P., Liang, M.C., Tan, G., Li, S., Snutch, T.P., Soong, T.W., Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels (2008) Molecular Pharmacology, 73, pp. 1596-1609
• Joels, M., Baram, T.Z., The neuro-symphony of stress (2009) Nature Reviews: Neuroscience, 10, pp. 459-466
• Chang, C.L., Hsu, S.Y., Ancient evolution of stress-regulating peptides in vertebrates (2004) Peptides, 25, pp. 1681-1688
• Dautzenberg, F.M., Hauger, R.L., The CRF peptide family and their receptors: Yet more partners discovered (2002) Trends in Pharmacological Sciences, 23, pp. 71-77
• Waters, R.P., Rivalan, M., Bangasser, D.A., Deussing, J.M., Ising, M., Wood, S.K., Holsboer, F., Summers, C.H., Evidence for the role of corticotropin-releasing factor in major depressive disorder (2015) Neuroscience and Biobehavioral Reviews, 58, pp. 63-78
• Gourcerol, G., Wu, S.V., Yuan, P.Q., Pham, H., Miampamba, M., Larauche, M., Sanders, P., Im, E., Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents (2011) Gastroenterology, 140, pp. e1586-e1596
• Hasdemir, B., Mahajan, S., Bunnett, N.W., Liao, M., Bhargava, A., Endothelin-converting enzyme-1 actions determine differential trafficking and signaling of corticotropin-releasing factor receptor 1 at high agonist concentrations (2012) Molecular Endocrinology, 26, pp. 681-695
• Potter, E., Behan, D.P., Fischer, W.H., Linton, E.A., Lowry, P.J., Vale, W.W., Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins (1991) Nature, 349, pp. 423-426
• Westphal, N.J., Seasholtz, A.F., CRH-BP: The regulation and function of a phylogenetically conserved binding protein (2006) Frontiers in Bioscience, 11, pp. 1878-1891
• Trainer, P.J., Woods, R.J., Korbonits, M., Popovic, V., Stewart, P.M., Lowry, P.J., Grossman, A.B., The pathophysiology of circulating corticotropin-releasing hormone-binding protein levels in the human (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 1611-1614
• Slater, P.G., Cerda, C.A., Pereira, L.A., Andres, M.E., Gysling, K., CRF binding protein facilitates the presence of CRF type 2alpha receptor on the cell surface (2016) PNAS, 113, pp. 4075-4080
• Lagerstrom, M.C., Schioth, H.B., Structural diversity of G protein-coupled receptors and significance for drug discovery (2008) Nature Reviews Drug Discovery, 7, pp. 339-357
• Culhane, K.J., Liu, Y., Cai, Y., Yan, E.C., Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors (2015) Frontiers in Pharmacology, 6, p. 264
• Grace, C.R., Perrin, M.H., Gulyas, J., Digruccio, M.R., Cantle, J.P., Rivier, J.E., Vale, W.W., Riek, R., Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand (2007) PNAS, 104, pp. 4858-4863
• Pioszak, A.A., Parker, N.R., Suino-Powell, K., Xu, H.E., Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1 (2008) Journal of Biological Chemistry, 283, pp. 32900-32912
• Grace, C.R., Perrin, M.H., Gulyas, J., Rivier, J.E., Vale, W.W., Riek, R., NMR structure of the first extracellular domain of corticotropin-releasing factor receptor 1 (ECD1-CRF-R1) complexed with a high affinity agonist (2010) Journal of Biological Chemistry, 285, pp. 38580-38589
• Pal, K., Swaminathan, K., He, X., Pioszak, A.A., Structural basis for hormone recognition by the Human CRFR2(alpha) G protein-coupled receptor (2010) Journal of Biological Chemistry, 285, pp. 40351-40361
• Rutz, C., Renner, A., Alken, M., Schulz, K., Beyermann, M., Wiesner, B., Rosenthal, W., Schulein, R., The corticotropin-releasing factor receptor type 2a contains an N-terminal pseudo signal peptide (2006) Journal of Biological Chemistry, 281, pp. 24910-24921
• Schulz, K., Rutz, C., Westendorf, C., Ridelis, I., Vogelbein, S., Furkert, J., Schmidt, A., Schulein, R., The pseudo signal peptide of the corticotropin-releasing factor receptor type 2a decreases receptor expression and prevents Gi-mediated inhibition of adenylyl cyclase activity (2010) Journal of Biological Chemistry, 285, pp. 32878-32887
• Slater, P.G., Yarur, H.E., Gysling, K., Corticotropin-releasing factor receptors and their interacting proteins: Functional consequences (2016) Molecular Pharmacology, 90, pp. 627-632
• Gkountelias, K., Tselios, T., Venihaki, M., Deraos, G., Lazaridis, I., Rassouli, O., Gravanis, A., Liapakis, G., Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding (2009) Molecular Pharmacology, 75, pp. 793-800
• Teichmann, A., Rutz, C., Kreuchwig, A., Krause, G., Wiesner, B., Schulein, R., The Pseudo signal peptide of the corticotropin-releasing factor receptor type 2A prevents receptor oligomerization (2012) Journal of Biological Chemistry, 287, pp. 27265-27274
• Holsboer, F., Ising, M., Stress hormone regulation: Biological role and translation into therapy (2010) Annual Review of Psychology, 61, pp. C101-C111
• Beurel, E., Nemeroff, C.B., Interaction of stress, corticotropin-releasing factor, arginine vasopressin and behaviour (2014) Current Topics in Behavioral Neurosciences, 18, pp. 67-80
• Birnbaumer, M., Vasopressin receptors (2000) Trends in Endocrinology and Metabolism, 11, pp. 406-410
• Abou-Samra, A.B., Harwood, J.P., Manganiello, V.C., Catt, K.J., Aguilera, G., Phorbol 12-myristate 13-acetate and vasopressin potentiate the effect of corticotropin-releasing factor on cyclic AMP production in rat anterior pituitary cells. Mechanisms of action (1987) Journal of Biological Chemistry, 262, pp. 1129-1136
• Cornett, L.E., Kang, S.W., Kuenzel, W.J., A possible mechanism contributing to the synergistic action of vasotocin (VT) and corticotropin-releasing hormone (CRH) receptors on corticosterone release in birds (2013) General and Comparative Endocrinology, 188, pp. 46-53
• Mikhailova, M.V., Mayeux, P.R., Jurkevich, A., Kuenzel, W.J., Madison, F., Periasamy, A., Chen, Y., Cornett, L.E., Heterooligomerization between vasotocin and corticotropin-releasing hormone (CRH) receptors augments CRH-stimulated 3′,5′-cyclic adenosine monophosphate production (2007) Molecular Endocrinology, 21, pp. 2178-2188
• Young, S.F., Griffante, C., Aguilera, G., Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors (2007) Cellular and Molecular Neurobiology, 27, pp. 439-461
• Murat, B., Devost, D., Andres, M., Mion, J., Boulay, V., Corbani, M., Zingg, H.H., Guillon, G., V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH (2012) Molecular Endocrinology, 26, pp. 502-520
• Wanat, M.J., Hopf, F.W., Stuber, G.D., Phillips, P.E., Bonci, A., Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih (2008) Journal of Physiology, 586, pp. 2157-2170
• Hahn, J., Hopf, F.W., Bonci, A., Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons (2009) Journal of Neuroscience, 29, pp. 6535-6544
• Fuenzalida, J., Galaz, P., Araya, K.A., Slater, P.G., Blanco, E.H., Campusano, J.M., Ciruela, F., Gysling, K., Dopamine D1 and corticotrophin-releasing hormone type-2alpha receptors assemble into functionally interacting complexes in living cells (2014) British Journal of Pharmacology, 171, pp. 5650-5664
• Navarro, G., Quiroz, C., Moreno-Delgado, D., Sierakowiak, A., McDowell, K., Moreno, E., Rea, W., Howell, L.A., Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine (2015) Journal of Neuroscience, 35, pp. 6639-6653
• Magalhaes, A.C., Holmes, K.D., Dale, L.B., Comps-Agrar, L., Lee, D., Yadav, P.N., Drysdale, L., Ferguson, S.S., CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling (2010) Nature Neuroscience, 13, pp. 622-629
• Markovic, D., Punn, A., Lehnert, H., Grammatopoulos, D.K., Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades (2008) Molecular Endocrinology, 22, pp. 689-706
• Bender, J., Engeholm, M., Ederer, M.S., Breu, J., Moller, T.C., Michalakis, S., Rasko, T., Martinez, K.L., Corticotropin-releasing hormone receptor type 1 (CRHR1) clustering with MAGUKs is mediated via its C-terminal PDZ binding motif (2015) Plos ONE, 10
• Dunn, H.A., Chahal, H.S., Caetano, F.A., Holmes, K.D., Yuan, G.Y., Parikh, R., Heit, B., Ferguson, S.S., PSD-95regulates CRFR1 localization, trafficking and beta-arrestin2 recruitment (2016) Cellular Signalling, 28, pp. 531-540
• Marcinkiewcz, C.A., Mazzone, C.M., D'agostino, G., Halladay, L.R., Hardaway, J.A., Diberto, J.F., Navarro, M., Dorrier, C.E., Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala (2016) Nature, 537, pp. 97-101
• Hollenstein, K., Kean, J., Bortolato, A., Cheng, R.K., Dore, A.S., Jazayeri, A., Cooke, R.M., Marshall, F.H., Structure of class B GPCR corticotropin-releasing factor receptor 1 (2013) Nature, 499, pp. 438-443
• Siu, F.Y., He, M., De Graaf, C., Han, G.W., Yang, D., Zhang, Z., Zhou, C., Joseph, J.S., Structure of the human glucagon class B G-protein-coupled receptor (2013) Nature, 499, pp. 444-449
• Wootten, D., Miller, L.J., Koole, C., Christopoulos, A., Sexton, P.M., Allostery and biased agonism at class B G protein-coupled receptors (2017) Chemical Reviews, 117, pp. 111-138
• Liang, Y.L., Khoshouei, M., Radjainia, M., Zhang, Y., Glukhova, A., Tarrasch, J., Thal, D.M., Coudrat, T., Phase-plate cryo-EM structure of a class B GPCR-G-protein complex (2017) Nature, 546, pp. 118-123
• Rosenbaum, D.M., Rasmussen, S.G., Kobilka, B.K., The structure and function of G-protein-coupled receptors (2009) Nature, 459, pp. 356-363
• Latorraca, N.R., Venkatakrishnan, A.J., Dror, R.O., GPCR dynamics: Structures in motion (2017) Chemical Reviews, 117, pp. 139-155
• Vilardaga, J.P., Jean-Alphonse, F.G., Gardella, T.J., Endosomal generation of cAMP in GPCR signaling (2014) Nature Chemical Biology, 10, pp. 700-706
• Irannejad, R., Von Zastrow, M., GPCR signaling along the endocytic pathway (2014) Current Opinion in Cell Biology, 27, pp. 109-116
• Pavlos, N.J., Friedman, P.A., GPCR signaling and trafficking: The long and short of it (2016) Trends in Endocrinology and Metabolism, 28, pp. 213-226
• Grammatopoulos, D.K., Dai, Y., Randeva, H.S., Levine, M.A., Karteris, E., Easton, A.J., Hillhouse, E.W., A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes (1999) Molecular Endocrinology, 13, pp. 2189-2202
• Papadopoulou, N., Chen, J., Randeva, H.S., Levine, M.A., Hillhouse, E.W., Grammatopoulos, D.K., Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: The critical role of Ser301 for signaling switch and selectivity (2004) Molecular Endocrinology, 18, pp. 624-639
• Wietfeld, D., Heinrich, N., Furkert, J., Fechner, K., Beyermann, M., Bienert, M., Berger, H., Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells (2004) Journal of Biological Chemistry, 279, pp. 38386-38394
• Scheerer, P., Park, J.H., Hildebrand, P.W., Kim, Y.J., Krauss, N., Choe, H.W., Hofmann, K.P., Ernst, O.P., Crystal structure of opsin in its G-protein- interacting conformation (2008) Nature, 455, pp. 497-502
• Choe, H.W., Kim, Y.J., Park, J.H., Morizumi, T., Pai, E.F., Krauss, N., Hofmann, K.P., Ernst, O.P., Crystal structure of metarhodopsin II (2011) Nature, 471, pp. 651-655
• Rasmussen, S.G., Devree, B.T., Zou, Y., Kruse, A.C., Chung, K.Y., Kobilka, T.S., Thian, F.S., Calinski, D., Crystal structure of the beta2 adrenergic receptor-Gs protein complex (2011) Nature, 477, pp. 549-555
• Punn, A., Chen, J., Delidaki, M., Tang, J., Liapakis, G., Lehnert, H., Levine, M.A., Grammatopoulos, D.K., Mapping structural determinants within third intracellular loop that direct signaling specificity of type 1 corticotropin-releasing hormone receptor (2012) Journal of Biological Chemistry, 287, pp. 8974-8985
• Sutherland, E.W., Rall, T.W., Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles (1958) Journal of Biological Chemistry, 232, pp. 1077-1091
• De Herder, W.W., Heroes in endocrinology: Nobel prizes (2014) Endocrine Connections, 3, pp. RR94-R104
• Buxton, I.L., Brunton, L.L., Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes (1983) Journal of Biological Chemistry, 258, pp. 10233-10239
• Teli, T., Markovic, D., Levine, M.A., Hillhouse, E.W., Grammatopoulos, D.K., Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: Structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization (2005) Molecular Endocrinology, 19, pp. 474-490
• Inda, C., Dos Santos Claro, P.A., Bonfiglio, J.J., Senin, S.A., Maccarronex, G., Turck, C.W., Silberstein, S., Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling (2016) Journal of Cell Biology, 214, pp. 181-195
• Inda, C., Bonfiglio, J.J., Dos Santos Claro, P.A., Senin, S.A., Armando, N.G., Deussing, J.M., Silberstein, S., CAMP-dependent cell differentiation triggered by activated CRHR1 in hippocampal neuronal cells (2017) Scientific Reports, 7, p. 1944
• Cooper, D.M., Tabbasum, V.G., Adenylate cyclase-centred microdomains (2014) Biochemical Journal, 462, pp. 199-213
• Willoughby, D., Cooper, D.M., Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains (2007) Physiological Reviews, 87, pp. 965-1010
• Chen, Y., Cann, M.J., Litvin, T.N., Iourgenko, V., Sinclair, M.L., Levin, L.R., Buck, J., Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor (2000) Science, 289, pp. 625-628
• Jaiswal, B.S., Conti, M., Calcium regulation of the soluble adenylyl cyclase expressed in mammalian spermatozoa (2003) PNAS, 100, pp. 10676-10681
• Litvin, T.N., Kamenetsky, M., Zarifyan, A., Buck, J., Levin, L.R., Kinetic properties of ‘soluble’ adenylyl cyclase. Synergism between calcium and bicarbonate (2003) Journal of Biological Chemistry, 278, pp. 15922-15926
• Tresguerres, M., Levin, L.R., Buck, J., Intracellular cAMP signaling by soluble adenylyl cyclase (2011) Kidney International, 79, pp. 1277-1288
• Halm, S.T., Zhang, J., Halm, D.R., Beta-Adrenergic activation of electrogenic K+ and Cl− secretion in guinea pig distal colonic epithelium proceeds via separate cAMP signaling pathways (2010) American Journal of Physiology: Gastrointestinal and Liver Physiology, 299, pp. G81-G95
• Chen, J., Martinez, J., Milner, T.A., Buck, J., Levin, L.R., Neuronal expression of soluble adenylyl cyclase in the mammalian brain (2013) Brain Research, 1518, pp. 1-8
• Stiles, T.L., Kapiloff, M.S., Goldberg, J.L., The role of soluble adenylyl cyclase in neurite outgrowth (2014) Biochimica Et Biophysica Acta, 1842, pp. 2561-2568
• Ivonnet, P., Salathe, M., Conner, G.E., Hydrogen peroxide stimulation of CFTR reveals an Epac-mediated, soluble AC-dependent cAMP amplification pathway common to GPCR signalling (2015) British Journal of Pharmacology, 172, pp. 173-184
• Zaccolo, M., Pozzan, T., CAMP and Ca2+ interplay: A matter of oscillation patterns (2003) Trends in Neurosciences, 26, pp. 53-55
• Tojima, T., Hines, J.H., Henley, J.R., Kamiguchi, H., Second messengers and membrane trafficking direct and organize growth cone steering (2011) Nature Reviews: Neuroscience, 12, pp. 191-203
• Kovalovsky, D., Refojo, D., Liberman, A.C., Hochbaum, D., Pereda, M.P., Coso, O.A., Stalla, G.K., Arzt, E., Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: Involvement of calcium, protein kinase A, and MAPK pathways (2002) Molecular Endocrinology, 16, pp. 1638-1651
• Markovic, D., Punn, A., Lehnert, H., Grammatopoulos, D.K., Molecular determinants and feedback circuits regulating type 2 CRH receptor signal integration (2011) Biochimica Et Biophysica Acta, 1813, pp. 896-907
• Bonfiglio, J.J., Inda, C., Senin, S., Maccarrone, G., Refojo, D., Giacomini, D., Turck, C.W., Silberstein, S., B-Raf and CRHR1 internalization mediate biphasic ERK1/2 activation by CRH in hippocampal HT22 Cells (2013) Molecular Endocrinology, 27, pp. 491-510
• Van Kolen, K., Dautzenberg, F.M., Verstraeten, K., Royaux, I., De Hoogt, R., Gutknecht, E., Peeters, P.J., Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2 (2010) Neuropharmacology, 58, pp. 135-144
• Bonfiglio, J.J., Inda, C., Refojo, D., Holsboer, F., Arzt, E., Silberstein, S., The corticotropin-releasing hormone network and the hypothalamic-pituitary-adrenal axis: Molecular and cellular mechanisms involved (2011) Neuroendocrinology, 94, pp. 12-20
• Refojo, D., Echenique, C., Muller, M.B., Reul, J.M., Deussing, J.M., Wurst, W., Sillaber, I., Arzt, E., Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas (2005) PNAS, 102, pp. 6183-6188
• Matallanas, D., Birtwistle, M., Romano, D., Zebisch, A., Rauch, J., Von Kriegsheim, A., Kolch, W., Raf family kinases: Old dogs have learned new tricks (2011) Genes and Cancer, 2, pp. 232-260
• Baljuls, A., Kholodenko, B.N., Kolch, W., It takes two to tango– signalling by dimeric Raf kinases (2013) Molecular Biosystem, 9, pp. 551-558
• Shenoy, S.K., Lefkowitz, R.J., Beta-Arrestin-mediated receptor trafficking and signal transduction (2011) Trends in Pharmacological Sciences, 32, pp. 521-533
• Cibelli, G., Corsi, P., Diana, G., Vitiello, F., Thiel, G., Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways (2001) European Journal of Neuroscience, 13, pp. 1339-1348
• Emery, A.C., Eiden, M.V., Mustafa, T., Eiden, L.E., Rapgef2 connects GPCR-mediated cAMP signals to ERK activation in neuronal and endocrine cells (2013) Science Signal, 6, p. 51
• Grammatopoulos, D.K., Randeva, H.S., Levine, M.A., Katsanou, E.S., Hillhouse, E.W., Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: An effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins (2000) Molecular Endocrinology, 14, pp. 2076-2091
• Graziani, G., Tentori, L., Muzi, A., Vergati, M., Tringali, G., Pozzoli, G., Navarra, P., Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH- R1 receptor subtype (2007) Molecular and Cellular Endocrinology, 264, pp. 44-49
• Takai, Y., Sasaki, T., Matozaki, T., Small GTP-binding proteins (2001) Physiological Reviews, 81, pp. 153-208
• Swinny, J.D., Valentino, R.J., Corticotropin-releasing factor promotes growth of brain norepinephrine neuronal processes through Rho GTPase regulators of the actin cytoskeleton in rat (2006) European Journal of Neuroscience, 24, pp. 2481-2490
• Swinny, J.D., Metzger, F., Ijkema-Paassen, J., Gounko, N.V., Gramsbergen, A., Van Der Want, J.J., Corticotropin-releasing factor and urocortin differentially modulate rat Purkinje cell dendritic outgrowth and differentiation in vitro (2004) European Journal of Neuroscience, 19, pp. 1749-1758
• Chen, Y., Bender, R.A., Brunson, K.L., Pomper, J.K., Grigoriadis, D.E., Wurst, W., Baram, T.Z., Modulation of dendritic differentiation by corticotropin-releasing factor in the developing hippocampus (2004) PNAS, 101, pp. 15782-15787
• Gounko, N.V., Swinny, J.D., Kalicharan, D., Jafari, S., Corteen, N., Seifi, M., Bakels, R., Van Der Want, J.J., Corticotropin-releasing factor and urocortin regulate spine and synapse formation: Structural basis for stress-induced neuronal remodeling and pathology (2013) Molecular Psychiatry, 18, pp. 86-92
• Khan, S.M., Sleno, R., Gora, S., Zylbergold, P., Laverdure, J.P., Labbe, J.C., Miller, G.J., Hebert, T.E., The expanding roles of Gbetagamma subunits in G protein-coupled receptor signaling and drug action (2013) Pharmacological Reviews, 65, pp. 545-577
• Sternweis, P.C., The purified alpha subunits of Go and Gi from bovine brain require beta gamma for association with phospholipid vesicles (1986) Journal of Biological Chemistry, 261, pp. 631-637
• Crespo, P., Cachero, T.G., Xu, N., Gutkind, J.S., Dual effect of beta-adrenergic receptors on mitogen-activated protein kinase. Evidence for a beta gamma-dependent activation and a G alpha s-cAMP-mediated inhibition (1995) Journal of Biological Chemistry, 270, pp. 25259-25265
• Crespo, P., Xu, N., Simonds, W.F., Gutkind, J.S., Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits (1994) Nature, 369, pp. 418-420
• Coso, O.A., Teramoto, H., Simonds, W.F., Gutkind, J.S., Signaling from G protein-coupled receptors to c-Jun kinase involves beta gamma subunits of heterotrimeric G proteins acting on a Ras and Rac1-dependent pathway (1996) Journal of Biological Chemistry, 271, pp. 3963-3966
• Punn, A., Levine, M.A., Grammatopoulos, D.K., Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: The critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation (2006) Molecular Endocrinology, 20, pp. 3179-3195
• Stern, C.M., Meitzen, J., Mermelstein, P.G., Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gbetagamma signaling in hippocampal pyramidal neurons (2011) European Journal of Neuroscience, 34, pp. 671-681
• Stern, C.M., Luoma, J.I., Meitzen, J., Mermelstein, P.G., Corticotropin releasing factor-induced CREB activation in striatal neurons occurs via a novel Gbetagamma signaling pathway (2011) Plos ONE, 6
• Wehbi, V.L., Stevenson, H.P., Feinstein, T.N., Calero, G., Romero, G., Vilardaga, J.P., Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gbetagamma complex (2013) PNAS, 110, pp. 1530-1535
• Jean-Alphonse, F.G., Wehbi, V.L., Chen, J., Noda, M., Taboas, J.M., Xiao, K., Vilardaga, J.P., Beta2-adrenergic receptor control of endosomal PTH receptor signaling via Gbetagamma (2017) Nature Chemical Biology, 13, pp. 259-261
• Sigismund, S., Confalonieri, S., Ciliberto, A., Polo, S., Scita, G., Di Fiore, P.P., Endocytosis and signaling: Cell logistics shape the eukaryotic cell plan (2012) Physiological Reviews, 92, pp. 273-366
• Refojo, D., Schweizer, M., Kuehne, C., Ehrenberg, S., Thoeringer, C., Vogl, A.M., Dedic, N., Avrabos, C., Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1 (2011) Science, 333, pp. 1903-1907
• Holmes, K.D., Babwah, A.V., Dale, L.B., Poulter, M.O., Ferguson, S.S., Differential regulation of corticotropin releasing factor 1alpha receptor endocytosis and trafficking by beta-arrestins and Rab GTPases (2006) Journal of Neurochemistry, 96, pp. 934-949
• Hauger, R.L., Olivares-Reyes, J.A., Braun, S., Hernandez-Aranda, J., Hudson, C.C., Gutknecht, E., Dautzenberg, F.M., Oakley, R.H., Desensitization of human CRF2(A) receptor signaling governed by agonist potency and betaarrestin2 recruitment (2013) Regulatory Peptides, 186, pp. 62-76
• Gutknecht, E., Hauger, R.L., Van Der Linden, I., Vauquelin, G., Dautzenberg, F.M., Expression, binding, and signaling properties of CRF2(A) receptors endogenously expressed in human retinoblastoma Y79 cells: Passage-dependent regulation of functional receptors (2008) Journal of Neurochemistry, 104, pp. 926-936
• Valentino, R.J., Van Bockstaele, E., Bangasser, D., Sex-specific cell signaling: The corticotropin-releasing factor receptor model (2013) Trends in Pharmacological Sciences, 34, pp. 437-444
• Kubat, E., Mahajan, S., Liao, M., Ackerman, L., Ohara, P.T., Grady, E.F., Bhargava, A., Corticotropin-releasing factor receptor 2 mediates sex-specific cellular stress responses (2013) Molecular Medicine, 19, pp. 212-222
• Hasdemir, B., Mhaske, P., Paruthiyil, S., Garnett, E.A., Heyman, M.B., Matloubian, M., Bhargava, A., Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation (2016) American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 310, pp. R1244-R1257
• Benovic, J.L., Mayor, F., Jr., Somers, R.L., Caron, M.G., Lefkowitz, R.J., Light-dependent phosphorylation of rhodopsin by beta-adrenergic receptor kinase (1986) Nature, 321, pp. 869-872
• Moore, C.A., Milano, S.K., Benovic, J.L., Regulation of receptor trafficking by GRKs and arrestins (2007) Annual Review of Physiology, 69, pp. 451-482
• Dautzenberg, F.M., Braun, S., Hauger, R.L., GRK3 mediates desensitization of CRF1 receptors: A potential mechanism regulating stress adaptation (2001) American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 280, pp. R935-R946
• Kageyama, K., Hanada, K., Moriyama, T., Nigawara, T., Sakihara, S., Suda, T., G protein-coupled receptor kinase 2 involvement in desensitization of corticotropin-releasing factor (CRF) receptor type 1 by CRF in murine corticotrophs (2006) Endocrinology, 147, pp. 441-450
• Perry, S.J., Junger, S., Kohout, T.A., Hoare, S.R., Struthers, R.S., Grigoriadis, D.E., Maki, R.A., Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated (2005) Journal of Biological Chemistry, 280, pp. 11560-11568
• Hauger, R.L., Dautzenberg, F.M., Flaccus, A., Liepold, T., Spiess, J., Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: Rapid and reversible homologous desensitization but prolonged recovery (1997) Journal of Neurochemistry, 68, pp. 2308-2316
• Roseboom, P.H., Urben, C.M., Kalin, N.H., Persistent corticotropin-releasing factor (1) receptor desensitization and downregulation in the human neuroblastoma cell line IMR-32 (2001) Brain Research: Molecular Brain Research, 92, pp. 115-127
• Oakley, R.H., Olivares-Reyes, J.A., Hudson, C.C., Flores-Vega, F., Dautzenberg, F.M., Hauger, R.L., Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: A mechanism regulating stress and anxiety responses (2007) American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 293, pp. R209-R222
• Goodman, O.B., Jr., Krupnick, J.G., Santini, F., Gurevich, V.V., Penn, R.B., Gagnon, A.W., Keen, J.H., Benovic, J.L., Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor (1996) Nature, 383, pp. 447-450
• Gurevich, V.V., Gurevich, E.V., Arrestins: Critical players in trafficking of many GPCRs (2015) Progress in Molecular Biology and Translational Science, 132, pp. 1-14
• Luttrell, L.M., Ferguson, S.S., Daaka, Y., Miller, W.E., Maudsley, S., Della Rocca, G.J., Lin, F., Luttrell, D.K., Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes (1999) Science, 283, pp. 655-661
• Shenoy, S.K., Drake, M.T., Nelson, C.D., Houtz, D.A., Xiao, K., Madabushi, S., Reiter, E., Lefkowitz, R.J., Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor (2006) Journal of Biological Chemistry, 281, pp. 1261-1273
• Rasmussen, T.N., Novak, I., Nielsen, S.M., Internalization of the human CRF receptor 1 is independent of classical phosphorylation sites and of beta-arrestin 1 recruitment (2004) European Journal of Biochemistry, 271, pp. 4366-4374
• Bangasser, D.A., Curtis, A., Reyes, B.A., Bethea, T.T., Parastatidis, I., Ischiropoulos, H., Van Bockstaele, E.J., Valentino, R.J., Sex differences in corticotropin-releasing factor receptor signaling and trafficking: Potential role in female vulnerability to stress-related psychopathology (2010) Molecular Psychiatry, 15 (877), pp. 896-904
• Defea, K.A., Vaughn, Z.D., O’Bryan, E.M., Nishijima, D., Dery, O., Bunnett, N.W., The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex (2000) PNAS, 97, pp. 11086-11091
• Ahn, S., Shenoy, S.K., Wei, H., Lefkowitz, R.J., Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor (2004) Journal of Biological Chemistry, 279, pp. 35518-35525
• Ge, L., Ly, Y., Hollenberg, M., Defea, K., A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis (2003) Journal of Biological Chemistry, 278, pp. 34418-34426
• Hunton, D.L., Barnes, W.G., Kim, J., Ren, X.R., Violin, J.D., Reiter, E., Milligan, G., Lefkowitz, R.J., Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis (2005) Molecular Pharmacology, 67, pp. 1229-1236
• Patel, P.A., Tilley, D.G., Rockman, H.A., Physiologic and cardiac roles of beta-arrestins (2009) Journal of Molecular and Cellular Cardiology, 46, pp. 300-308
• Nuber, S., Zabel, U., Lorenz, K., Nuber, A., Milligan, G., Tobin, A.B., Lohse, M.J., Hoffmann, C., Beta-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle (2016) Nature, 531, pp. 661-664
• Lee, M.H., Appleton, K.M., Strungs, E.G., Kwon, J.Y., Morinelli, T.A., Peterson, Y.K., Laporte, S.A., Luttrell, L.M., The conformational signature of beta-arrestin2 predicts its trafficking and signalling functions (2016) Nature, 531, pp. 665-668
• Eichel, K., Jullie, D., Von Zastrow, M., Beta-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation (2016) Nature Cell Biology, 18, pp. 303-310
• Magalhaes, A.C., Dunn, H., Ferguson, S.S., Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins (2012) British Journal of Pharmacology, 165, pp. 1717-1736
• Couvineau, A., Laburthe, M., The family B1 GPCR: Structural aspects and interaction with accessory proteins (2012) Current Drug Targets, 13, pp. 103-115
• Slessareva, J.E., Routt, S.M., Temple, B., Bankaitis, V.A., Dohlman, H.G., Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein alpha subunit at the endosome (2006) Cell, 126, pp. 191-203
• Ferrandon, S., Feinstein, T.N., Castro, M., Wang, B., Bouley, R., Potts, J.T., Gardella, T.J., Vilardaga, J.P., Sustained cyclic AMP production by parathyroid hormone receptor endocytosis (2009) Nature Chemical Biology, 5, pp. 734-742
• Calebiro, D., Nikolaev, V.O., Gagliani, M.C., De Filippis, T., Dees, C., Tacchetti, C., Persani, L., Lohse, M.J., Persistent cAMP-signals triggered by internalized G-protein-coupled receptors (2009) Plos Biology, 7
• Mullershausen, F., Zecri, F., Cetin, C., Billich, A., Guerini, D., Seuwen, K., Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors (2009) Nature Chemical Biology, 5, pp. 428-434
• Kuna, R.S., Girada, S.B., Asalla, S., Vallentyne, J., Maddika, S., Patterson, J.T., Smiley, D.L., Mitra, P., Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic beta-cells (2013) American Journal of Physiology: Endocrinology and Metabolism, 305, pp. E161-E170
• Merriam, L.A., Baran, C.N., Girard, B.M., Hardwick, J.C., May, V., Parsons, R.L., Pituitary adenylate cyclase 1 receptor internalization and endosomal signaling mediate the pituitary adenylate cyclase activating polypeptide-induced increase in guinea pig cardiac neuron excitability (2013) Journal of Neuroscience, 33, pp. 4614-4622
• Feinstein, T.N., Yui, N., Webber, M.J., Wehbi, V.L., Stevenson, H.P., King, J.D., Jr., Hallows, K.R., Vilardaga, J.P., Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin (2013) Journal of Biological Chemistry, 288, pp. 27849-27860
• Kotowski, S.J., Hopf, F.W., Seif, T., Bonci, A., Von Zastrow, M., Endocytosis promotes rapid dopaminergic signaling (2011) Neuron, 71, pp. 278-290
• Irannejad, R., Tomshine, J.C., Tomshine, J.R., Chevalier, M., Mahoney, J.P., Steyaert, J., Rasmussen, S.G., Von Zastrow, M., Conformational biosensors reveal GPCR signalling from endosomes (2013) Nature, 495, pp. 534-538
• Tsvetanova, N.G., Von Zastrow, M., Spatial encoding of cyclic AMP signaling specificity by GPCR endocytosis (2014) Nature Chemical Biology, 10, pp. 1061-1065
• Shukla, A.K., Westfield, G.H., Xiao, K., Reis, R.I., Huang, L.Y., Tripathi-Shukla, P., Qian, J., Oleskie, A.N., Visualization of arrestin recruitment by a G-protein-coupled receptor (2014) Nature, 512, pp. 218-222
• Szczepek, M., Beyriere, F., Hofmann, K.P., Elgeti, M., Kazmin, R., Rose, A., Bartl, F.J., Sommer, M.E., Crystal structure of a common GPCR-binding interface for G protein and arrestin (2014) Nature Communications, 5, p. 4801
• Kang, Y., Zhou, X.E., Gao, X., He, Y., Liu, W., Ishchenko, A., Barty, A., Han, G.W., Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser (2015) Nature, 523, pp. 561-567
• Thomsen, A.R., Plouffe, B., Cahill, T.J., 3Rd, Shukla, A.K., Tarrasch, J.T., Dosey, A.M., Kahsai, A.W., Mahoney, J.P., GPCR-G protein-beta-arrestin super-complex mediates sustained G protein signaling (2016) Cell, 166, pp. 907-919
• Feinstein, T.N., Wehbi, V.L., Ardura, J.A., Wheeler, D.S., Ferrandon, S., Gardella, T.J., Vilardaga, J.P., Retromer terminates the generation of cAMP by internalized PTH receptors (2011) Nature Chemical Biology, 7, pp. 278-284
• Caldieri, G., Sigismund, S., Spatial resolution of cAMP signaling by soluble adenylyl cyclase (2016) Journal of Cell Biology, 214, pp. 125-127
• Bowman, S.L., Shiwarski, D.J., Puthenveedu, M.A., Distinct G protein-coupled receptor recycling pathways allow spatial control of downstream G protein signaling (2016) Journal of Cell Biology, 214, pp. 797-806
• Wang, G., Wei, Z., Wu, G., Role of Rab GTPases in the export trafficking of G protein-coupled receptors (2017) Small Gtpases, pp. 1-6
• Gidon, A., Al-Bataineh, M.M., Jean-Alphonse, F.G., Stevenson, H.P., Watanabe, T., Louet, C., Khatri, A., Gardella, T.J., Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase (2014) Nature Chemical Biology, 10, pp. 707-709
• Milan-Lobo, L., Gsandtner, I., Gaubitzer, E., Runzler, D., Buchmayer, F., Kohler, G., Bonci, A., Sitte, H.H., Subtype-specific differences in corticotropin-releasing factor receptor complexes detected by fluorescence spectroscopy (2009) Molecular Pharmacology, 76, pp. 1196-1210
• Watson, R.L., Buck, J., Levin, L.R., Winger, R.C., Wang, J., Arase, H., Muller, W.A., Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration (2015) Journal of Experimental Medicine, 212, pp. 1021-1041
• Namkung, Y., Le Gouill, C., Lukashova, V., Kobayashi, H., Hogue, M., Khoury, E., Song, M., Laporte, S.A., Monitoring G protein-coupled receptor and beta-arrestin trafficking in live cells using enhanced bystander BRET (2016) Nature Communications, 7, p. 12178
• Lohse, M.J., Calebiro, D., Cell biology: Receptor signals come in waves (2013) Nature, 495, pp. 457-458
• Van Gaalen, M.M., Stenzel-Poore, M.P., Holsboer, F., Steckler, T., Effects of transgenic overproduction of CRH on anxiety-like behaviour (2002) European Journal of Neuroscience, 15, pp. 2007-2015
• Griebel, G., Holsboer, F., Neuropeptide receptor ligands as drugs for psychiatric diseases: The end of the beginning? (2012) Nature Reviews Drug Discovery, 11, pp. 462-478
• Zorrilla, E.P., Valdez, G.R., Nozulak, J., Koob, G.F., Markou, A., Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat (2002) Brain Research, 952, pp. 188-199
• Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J.M., Stalla, G.K., Blanquet, V., Wurst, W., Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 (1998) Nature Genetics, 19, pp. 162-166
• Bale, T.L., Contarino, A., Smith, G.W., Chan, R., Gold, L.H., Sawchenko, P.E., Koob, G.F., Lee, K.F., Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress (2000) Nature Genetics, 24, pp. 410-414
• Coste, S.C., Kesterson, R.A., Heldwein, K.A., Stevens, S.L., Heard, A.D., Hollis, J.H., Murray, S.E., Hohimer, A.R., Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 (2000) Nature Genetics, 24, pp. 403-409
• Neufeld-Cohen, A., Tsoory, M.M., Evans, A.K., Getselter, D., Gil, S., Lowry, C.A., Vale, W.W., Chen, A., A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery (2010) PNAS, 107, pp. 19020-19025
• Shemesh, Y., Forkosh, O., Mahn, M., Anpilov, S., Sztainberg, Y., Manashirov, S., Shlapobersky, T., Ezra, G., Ucn3 and CRF-R2 in the medial amygdala regulate complex social dynamics (2016) Nature Neuroscience, 19, pp. 1489-1496
• Regev, L., Baram, T.Z., Corticotropin releasing factor in neuroplasticity (2014) Frontiers in Neuroendocrinology, 35, pp. 171-179
• Lemos, J.C., Wanat, M.J., Smith, J.S., Reyes, B.A., Hollon, N.G., Van Bockstaele, E.J., Chavkin, C., Phillips, P.E., Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive (2012) Nature, 490, pp. 402-406
• Holsboer, F., The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety (1999) Journal of Psychiatric Research, 33, pp. 181-214
• Binder, E.B., Nemeroff, C.B., The CRF system, stress, depression and anxiety-insights from human genetic studies (2010) Molecular Psychiatry, 15, pp. 574-588
• Zorrilla, E.P., Logrip, M.L., Koob, G.F., Corticotropin releasing factor: A key role in the neurobiology of addiction (2014) Frontiers in Neuroendocrinology, 35, pp. 234-244
• Raglan, G.B., Schmidt, L.A., Schulkin, J., The role of glucocorticoids and corticotropin-releasing hormone regulation on anxiety symptoms and response to treatment (2017) Endocrine Connections, 6, pp. R1-R7
• Arborelius, L., Owens, M.J., Plotsky, P.M., Nemeroff, C.B., The role of corticotropin-releasing factor in depression and anxiety disorders (1999) Journal of Endocrinology, 160, pp. 1-12
• Nemeroff, C.B., Widerlov, E., Bissette, G., Walleus, H., Karlsson, I., Eklund, K., Kilts, C.D., Vale, W., Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients (1984) Science, 226, pp. 1342-1344
• Bremner, J.D., Licinio, J., Darnell, A., Krystal, J.H., Owens, M.J., Southwick, S.M., Nemeroff, C.B., Charney, D.S., Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder (1997) American Journal of Psychiatry, 154, pp. 624-629
• De Bellis, M.D., Gold, P.W., Geracioti, T.D., Jr., Listwak, S.J., Kling, M.A., Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression (1993) American Journal of Psychiatry, 150, pp. 656-657
• Heuser, I., Bissette, G., Dettling, M., Schweiger, U., Gotthardt, U., Schmider, J., Lammers, C.H., Holsboer, F., Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment (1998) Depression and Anxiety, 8, pp. 71-79
• Merali, Z., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M.O., Anisman, H., Dysregulation in the suicide brain: MRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region (2004) Journal of Neuroscience, 24, pp. 1478-1485
• Byers, A.L., Yaffe, K., Depression and risk of developing dementia (2011) Nature Reviews: Neurology, 7, pp. 323-331

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------